Quarterly report · Q2
4188.TEDINET S100PK3O
Period2022-04-01 → 2022-09-30
Filed2022-11-11
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 62
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.27T | 2022-04-01 → 2022-09-30 | Cons. | Revenue IFRS |
| Revenue | ¥1.16T | 2022-07-01 → 2022-09-30d | Cons. | Revenue IFRS |
| Revenue | ¥3.98T | 2021-04-01 → 2022-03-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.89T | 2021-04-01 → 2021-09-30 | Cons. | Revenue IFRS |
| Revenue | ¥956.8bn | 2021-07-01 → 2021-09-30d | Cons. | Revenue IFRS |
| Operating income | ¥118.4bn | 2022-04-01 → 2022-09-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥50.3bn | 2022-07-01 → 2022-09-30d | Cons. | Operating profit loss IFRS |
| Operating income | ¥153.1bn | 2021-04-01 → 2021-09-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥66.1bn | 2021-07-01 → 2021-09-30d | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥122.0bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥46.9bn | 2022-07-01 → 2022-09-30d | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥290.4bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥147.2bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥61.9bn | 2021-07-01 → 2021-09-30d | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥73.9bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥29.1bn | 2022-07-01 → 2022-09-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥177.2bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥85.2bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥35.2bn | 2021-07-01 → 2021-09-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥91.5bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss IFRS |
| Net income | ¥38.2bn | 2022-07-01 → 2022-09-30d | Cons. | Profit loss IFRS |
| Net income | ¥209.4bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥101.9bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss IFRS |
| Net income | ¥42.7bn | 2021-07-01 → 2021-09-30d | Cons. | Profit loss IFRS |
| Total assets | ¥6.00T | at 2022-09-30 | Cons. | Assets IFRS |
| Total assets | ¥5.57T | at 2022-03-31 | Cons. | Assets IFRS |
| Total assets | ¥5.32T | at 2021-09-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥3.96T | at 2022-09-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥3.73T | at 2022-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥2.04T | at 2022-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.84T | at 2022-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.67T | at 2021-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.57T | at 2021-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥1.63T | at 2022-09-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.46T | at 2022-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.32T | at 2021-09-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥253.7bn | at 2022-09-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥245.8bn | at 2022-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥257.7bn | at 2021-09-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥349.6bn | at 2021-03-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥93.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥346.9bn | 2021-04-01 → 2022-03-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥166.3bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥117.7bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥128.8bn | 2021-04-01 → 2022-03-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥107.5bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | ¥15.6bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥336.3bn | 2021-04-01 → 2022-03-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥151.4bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥52.02 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥20.44 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥124.68 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥59.94 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥24.8 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥49.79 | 2022-04-01 → 2022-09-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥19.58 | 2022-07-01 → 2022-09-30d | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥115.03 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥55.13 | 2021-04-01 → 2021-09-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥22.82 | 2021-07-01 → 2021-09-30d | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 27.1% | at 2022-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 26.2% | at 2022-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 24.8% | at 2021-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 62
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-09-30 | ¥205.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-09-30 | ¥108.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥96.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-09-30 | ¥6.6bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥152.9bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥152.9bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥6.4bn |
| jpcrp040300-q2r_E00808-000Chemicalsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥771.4bn |
| jpcrp040300-q2r_E00808-000Chemicalsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥745.4bn |
| jpcrp040300-q2r_E00808-000Chemicalsreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥26.0bn |
| jpcrp040300-q2r_E00808-000Chemicalsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥22.7bn |
| jpcrp040300-q2r_E00808-000Health Carereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥212.3bn |
| jpcrp040300-q2r_E00808-000Health Carereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥212.0bn |
| jpcrp040300-q2r_E00808-000Health Carereportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥309m |
| jpcrp040300-q2r_E00808-000Health Carereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥3.1bn |
| jpcrp040300-q2r_E00808-000Industrial Gasesreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥573.7bn |
| jpcrp040300-q2r_E00808-000Industrial Gasesreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥569.3bn |
| jpcrp040300-q2r_E00808-000Industrial Gasesreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥4.4bn |
| jpcrp040300-q2r_E00808-000Industrial Gasesreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥54.3bn |
| jpcrp040300-q2r_E00808-000Performance Productsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥659.7bn |
| jpcrp040300-q2r_E00808-000Performance Productsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥634.3bn |
| jpcrp040300-q2r_E00808-000Performance Productsreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥25.3bn |
| jpcrp040300-q2r_E00808-000Performance Productsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥42.3bn |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥2.22T |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥2.16T |
| —segment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥56.1bn |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥122.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥2.42T |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥2.27T |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥152.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥129.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2021-09-30 | ¥172.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2021-09-30 | ¥81.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥90.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2021-09-30 | ¥6.1bn |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-09-30 | −¥140.6bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-09-30 | −¥140.6bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-09-30 | −¥7.3bn |
| jpcrp040300-q2r_E00808-000Chemicalsreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥614.8bn |
| jpcrp040300-q2r_E00808-000Chemicalsreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥593.9bn |
| jpcrp040300-q2r_E00808-000Chemicalsreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥20.9bn |
| jpcrp040300-q2r_E00808-000Chemicalsreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥62.2bn |
| jpcrp040300-q2r_E00808-000Health Carereportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥198.7bn |
| jpcrp040300-q2r_E00808-000Health Carereportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥198.5bn |
| jpcrp040300-q2r_E00808-000Health Carereportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥171m |
| jpcrp040300-q2r_E00808-000Health Carereportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥1.1bn |
| jpcrp040300-q2r_E00808-000Industrial Gasesreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥447.4bn |
| jpcrp040300-q2r_E00808-000Industrial Gasesreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥444.1bn |
| jpcrp040300-q2r_E00808-000Industrial Gasesreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥3.3bn |
| jpcrp040300-q2r_E00808-000Industrial Gasesreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥48.3bn |
| jpcrp040300-q2r_E00808-000Performance Productsreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥592.2bn |
| jpcrp040300-q2r_E00808-000Performance Productsreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥566.7bn |
| jpcrp040300-q2r_E00808-000Performance Productsreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥25.5bn |
| jpcrp040300-q2r_E00808-000Performance Productsreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥45.8bn |
| —segment total | revenue | 2021-04-01 → 2021-09-30 | ¥1.85T |
| —segment total | revenue external | 2021-04-01 → 2021-09-30 | ¥1.80T |
| —segment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥49.8bn |
| —segment total | segment profit | 2021-04-01 → 2021-09-30 | ¥157.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-09-30 | ¥2.03T |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-09-30 | ¥1.89T |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥140.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-09-30 | ¥163.5bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 950
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row2Member | - | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row2Member | 2400 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row2Member | 0.0000 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row3Member | 2800 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row3Member | - | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row3Member | 2800 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row3Member | 0.0000 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row4Member | 169900 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row4Member | - | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row4Member | 169900 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row4Member | 0.0001 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 82055200 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | - | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 82055200 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.0545 | |
| Number of male directors and other officers | FilingDateInstant | 16 | |
| Number of female directors and other officers | FilingDateInstant | 3 | |
| Ratio of female directors and other officers | FilingDateInstant | 0.158 | |
| Revenue IFRS | Prior1YTDDuration | 1885095000000 | JPY |
| Revenue IFRS | CurrentYTDDuration | 2269808000000 | JPY |
| Cost of sales IFRS | Prior1YTDDuration | 1326160000000 | JPY |
| Cost of sales IFRS | CurrentYTDDuration | 1696653000000 | JPY |
| Gross profit IFRS | Prior1YTDDuration | 558935000000 | JPY |
| Gross profit IFRS | CurrentYTDDuration | 573155000000 | JPY |
| Selling general and administrative expenses IFRS | Prior1YTDDuration | 410690000000 | JPY |
| Selling general and administrative expenses IFRS | CurrentYTDDuration | 455142000000 | JPY |
| Other operating income IFRS | Prior1YTDDuration | 8528000000 | JPY |
| Other operating income IFRS | CurrentYTDDuration | 8379000000 | JPY |
| Other operating expenses IFRS | Prior1YTDDuration | 13279000000 | JPY |
| Other operating expenses IFRS | CurrentYTDDuration | 15247000000 | JPY |
| Share of profit loss of investments accounted for using equity method IFRS | Prior1YTDDuration | 9643000000 | JPY |
| Share of profit loss of investments accounted for using equity method IFRS | CurrentYTDDuration | 7207000000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration | 153137000000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration | 118352000000 | JPY |
| Finance income IFRS | Prior1YTDDuration | 5418000000 | JPY |
| Finance income IFRS | CurrentYTDDuration | 16538000000 | JPY |
| Finance costs IFRS | Prior1YTDDuration | 11390000000 | JPY |
| Finance costs IFRS | CurrentYTDDuration | 12923000000 | JPY |
| Profit loss before tax IFRS | Prior1YTDDuration | 147165000000 | JPY |
| Profit loss before tax IFRS | CurrentYTDDuration | 121967000000 | JPY |
| Income tax expense IFRS | Prior1YTDDuration | 45230000000 | JPY |
| Income tax expense IFRS | CurrentYTDDuration | 30439000000 | JPY |
| Profit loss IFRS | Prior1YTDDuration | 101935000000 | JPY |
| Profit loss IFRS | CurrentYTDDuration | 91528000000 | JPY |
| Profit loss attributable to owners of parent IFRS | Prior1YTDDuration | 85166000000 | JPY |
| Profit loss attributable to owners of parent IFRS | CurrentYTDDuration | 73944000000 | JPY |
| Profit loss attributable to non controlling interests IFRS | Prior1YTDDuration | 16769000000 | JPY |
| Profit loss attributable to non controlling interests IFRS | CurrentYTDDuration | 17584000000 | JPY |
| Basic earnings loss per share IFRS | Prior1YTDDuration | 59.94 | |
| Basic earnings loss per share IFRS | CurrentYTDDuration | 52.02 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 16 of 16 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |